©The Author(s) 2025.
World J Diabetes. Oct 15, 2025; 16(10): 110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Published online Oct 15, 2025. doi: 10.4239/wjd.v16.i10.110406
Table 1 Comparison of baseline clinical characteristics in type 2 diabetes mellitus patients grouped according to metabolic dysfunction-associated steatotic liver disease status, mean ± SD/n (%)
| Variables | Total (n = 688) | Non-MASLD (n = 345) | MASLD (n = 343) | P value |
| Age (years) | 56.71 ± 12.73 | 59.97 ± 11.9 | 53.44 ± 12.72 | < 0.001 |
| BMI (kg/m2) | 25.16 ± 3.64 | 23.88 ± 3.21 | 26.45 ± 3.59 | < 0.001 |
| SBP (mmHg) | 129.38 ± 18.11 | 128.11 ± 18.75 | 130.66 ± 17.37 | 0.064 |
| DBP (mmHg) | 78.37 ± 11.56 | 75.43 ± 11.1 | 81.33 ± 11.27 | < 0.001 |
| HbA1c (%) | 9.10 ± 2.29 | 9.08 ± 2.50 | 9.12 ± 2.06 | 0.835 |
| WBC (× 109/L) | 6.35 ± 1.71 | 6.11 ± 1.55 | 6.60 ± 1.82 | < 0.001 |
| RBC (× 1012/L), median (Q1, Q3) | 4.57 (4.22, 4.94) | 4.46 (4.09, 4.85) | 4.70 (4.35, 5.03) | 0.291 |
| PLT (× 109/L) | 190.45 ± 56.48 | 186.71 ± 61.13 | 194.20 ± 51.19 | 0.083 |
| TP (g/L) | 65.23 ± 5.62 | 64.75 ± 5.53 | 65.72 ± 5.68 | 0.024 |
| ALT (U/L) | 29.08 ± 30.09 | 23.61 ± 29.12 | 34.59 ± 30.09 | < 0.001 |
| AST (U/L) | 24.99 ± 23.85 | 22.13 ± 16.25 | 27.87 ± 29.34 | 0.002 |
| BUN (mmol/L) | 6.69 ± 2.35 | 7.13 ± 2.4 | 6.24 ± 2.21 | < 0.001 |
| TC (mmol/L) | 4.72 ± 1.44 | 4.57 ± 1.47 | 4.87 ± 1.39 | 0.007 |
| TG (mmol/L) | 2.33 ± 2.68 | 1.76 ± 1.67 | 2.91 ± 3.31 | < 0.001 |
| HDL-C (mmol/L) | 1.10 ± 0.32 | 1.14 ± 0.27 | 1.06 ± 0.35 | < 0.001 |
| LDL-C (mmol/L) | 2.82 ± 0.93 | 2.71 ± 0.88 | 2.93 ± 0.97 | 0.003 |
| FBG (mmol/L) | 8.51 ± 3.87 | 8.48 ± 4.41 | 8.53 ± 3.24 | 0.863 |
| ZJU index | 40.07 ± 7.03 | 37.88 ± 6.67 | 42.27 ± 6.7 | < 0.001 |
| Scr (mmol/L) | 61.00 (49, 72) | 61.00 (50, 75) | 60.00 (49, 70) | 0.143 |
| UA (mmol/L), median (Q1, Q3) | 326.00 (267.5, 386) | 310.00 (255, 372) | 346.00 (284, 409.5) | < 0.001 |
| Sex (male) | 458 (66.57) | 221 (64.06) | 237 (69.1) | 0.161 |
| Smoking | 254 (36.92) | 120 (34.78) | 134 (39.07) | 0.244 |
| Drinking | 272 (39.53) | 115 (33.33) | 157 (45.77) | < 0.001 |
| Hypertension | 360 (52.33) | 172 (49.86) | 188 (54.81) | 0.193 |
| CAD | 71 (10.32) | 46 (13.33) | 25 (7.29) | 0.009 |
- Citation: Tao XY, Pan TR, Zhong X, Pan XY. Association between Zhejiang University index and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus. World J Diabetes 2025; 16(10): 110406
- URL: https://www.wjgnet.com/1948-9358/full/v16/i10/110406.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i10.110406